William Blair initiated coverage of Butterfly Network with a rating of Outperform
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/1/2025 | Outperform → Perform | Oppenheimer | |
| 7/1/2025 | $3.00 | Buy | Craig Hallum |
| 3/17/2025 | Outperform | William Blair | |
| 9/10/2024 | $3.00 | Buy | Lake Street |
| 3/29/2023 | $2.25 | Neutral | UBS |
| 11/29/2022 | $4.50 | Outperform | Oppenheimer |
| 10/4/2022 | $9.50 | Buy | B. Riley Securities |
| 12/17/2021 | $7.00 | Neutral | UBS |
144 - Butterfly Network, Inc. (0001804176) (Subject)
144 - Butterfly Network, Inc. (0001804176) (Subject)
144 - Butterfly Network, Inc. (0001804176) (Subject)
Oppenheimer downgraded Butterfly Network from Outperform to Perform
Craig Hallum initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $3.00
William Blair initiated coverage of Butterfly Network with a rating of Outperform
4 - Butterfly Network, Inc. (0001804176) (Issuer)
4 - Butterfly Network, Inc. (0001804176) (Issuer)
4 - Butterfly Network, Inc. (0001804176) (Issuer)
Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report second quarter 2026 financial results on Thursday, July 30, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast before the market opens on July 30 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly’s Investor Relations website at Events & Presentations.
Expansion into one of Latin America's largest healthcare markets advances Butterfly's international growth strategy and mission to democratize medical imaging Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the commercial availability of its Butterfly iQ+ and iQ3 handheld ultrasound devices and mobile application in Brazil through a network of authorized distribution partners. Brazil is the largest medical device market in Latin America and one of the fastest-growing ultrasound markets globally,1,2 representing a significant opportunity to expand access to medical imagi
Brain-computer interface research lab building on Butterfly's Ultrasound-on-Chip™ platform achieves what it deems a breakthrough in non-invasive neuroimaging, with implications for how humans may one day communicate and connect. Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today responded to Aleph Neuro (Aleph)'s public launch and announcement of what it describes as a breakthrough in non-invasive brain imaging using ultrasound. Aleph is a participant in the Butterfly Embedded™ licensing and co-development program powering a new wave of ultrasound-enabled technologies. This press rel
4 - Butterfly Network, Inc. (0001804176) (Issuer)
4 - Butterfly Network, Inc. (0001804176) (Issuer)
4 - Butterfly Network, Inc. (0001804176) (Issuer)
Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report second quarter 2026 financial results on Thursday, July 30, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast before the market opens on July 30 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly’s Investor Relations website at Events & Presentations.
Delivered Revenue Above Consensus and Beat Adjusted EBITDA Guidance Reaffirmed full year Revenue and Adjusted EBITDA Guidance Delivered quarterly Revenue of $26.5 million in Q1, representing 25% YoY growth Delivered 69% Gross Margin up 600 bps and Adjusted EBITDA of ($6.1M) up 32% YoY Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced financial results for the first quarter ended March 31, 2026, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, "Butterfly opened the year with ano
Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report first quarter 2026 financial results on Thursday, April 30, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast before the market opens on April 30 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website at Events & Presentations.
VMS+™ 4.0 system collects a 2026 Edison Award Gold Medal, advances to NMPA regulatory submission in China, and heads to the AEPC pediatric cardiology meeting in Padua, Italy VANCOUVER, British Columbia, May 13, 2026 (GLOBE NEWSWIRE) -- USA News Group News Commentary — The AI-cardiac-diagnostics category is one of the more measurable inflection points in the broader medtech sector heading into the second half of 2026. The global AI cardiology market is projected to reach approximately US$2.78 billion in 2026 and climb past US$14 billion by 2034 as software-based diagnostics replace hardware-based imaging across an aging patient base and a healthcare system increasingly cost-pressured at
Seasoned Medtech Leader and Former Chairman and CEO of B. Braun of America Brings Deep Healthcare Industry Expertise Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Caroll H. Neubauer to its Board of Directors, effective May 18, 2026. Mr. Neubauer will serve on the Board's Compensation Committee and Technology Committee. Mr. Neubauer has achieved a distinguished career spanning three decades with B. Braun, including serving for 29 years on the Global Management Board of the B. Braun Group of Companies. During his tenure, he helped grow annual revenue
Prominent POCUS thought leader joins to advance clinical strategy and further Butterfly's mission to democratize ultrasound worldwide. Butterfly Network (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Arun Nagdev, MD as Chief Medical Officer – Point-of-Care Ultrasound (POCUS). In this role, Dr. Nagdev will lead the global medical strategy for the Company's core POCUS business, advancing clinical product validation, strengthening customer engagement, and supporting regulatory and clinical development efforts. Dr. Nagdev brings more than 20 years of experience advancing POCUS adoption, educ
SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)
SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)
SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)